Author:
Ranza E.,Mazzini G.,Facoetti A.,Nano R.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Neurology (clinical),Neurology,Oncology
Reference35 articles.
1. Kilic T, Alberta JA, Zdunek PR, Acar M, Iannarelli P, O’Reilly T, Buchdunger E, Black PM, Stiles CD (2000) Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class. Cancer Res 18:5143–5150
2. Salgaller ML, Liau LM (2006) Current status of clinical trials for glioblastoma. Rev Recent Clin Trials 3:265–281
3. Johnson LN (2009) Protein kinase inhibitors: contributions from structure to clinical compounds. Q Rev Biophys 19:1–40
4. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70
5. Al-Obeidi FA, Lam KS (2000) The protein tyrosine kinase family of the human genome. Oncogene 19:5548–5557
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献